Literature DB >> 20827738

At the nanoscale: nanohemostat, a new class of hemostatic agent.

Rutledge Ellis-Behnke1.   

Abstract

Three basic categories of hemostats are widely used in surgery today: chemical agents, thermal devices, and mechanical methods that use pressure or ligature to slow bleeding. Each has its benefits and limitations. However, nanotechnology is rapidly ushering in new medical technologies. This review focuses on the 'nanohemostat', a new class of hemostatic agent that stops bleeding in less than 15 seconds by using (RADA)4, referred to as nanohemostat-1 (NHS-1), a synthetic biological material that self-assembles at the nanoscale when applied to a wound, and compares it to the characteristics of the 'ideal hemostat'. (c) 2010 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20827738     DOI: 10.1002/wnan.110

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  6 in total

1.  Nano-hemostats and a Pilot Study of Their Use in a Large Animal Model of Major Vessel Hemorrhage in Endoscopic Skull Base Surgery.

Authors:  Alistair Jukes; Jae Murphy; Sarah Vreugde; Alkis Psaltis; P J Wormald
Journal:  J Neurol Surg B Skull Base       Date:  2016-12-12

2.  Endoscopically delivered Purastat for the treatment of severe haemorrhagic radiation proctopathy: a service evaluation of a new endoscopic treatment for a challenging condition.

Authors:  Katherine White; Caroline Claire Henson
Journal:  Frontline Gastroenterol       Date:  2021-01-19

3.  Engineered isopeptide bond stabilized fibrin inspired nanoscale peptide based sealants for efficient blood clotting.

Authors:  Snehasish Ghosh; Sanchita Mukherjee; Chiranjit Dutta; Kasturee Chakraborty; Paramita Gayen; Somnath Jan; Dhananjay Bhattacharyya; Rituparna Sinha Roy
Journal:  Sci Rep       Date:  2017-07-26       Impact factor: 4.379

4.  Generation of Chimeric "ABS Nanohemostat" Complex and Comparing Its Histomorphological In Vivo Effects to the Traditional Ankaferd Hemostat in Controlled Experimental Partial Nephrectomy Model.

Authors:  Emre Huri; Yavuz Beyazit; Rashad Mammadov; Sila Toksoz; Ayse B Tekinay; Mustafa O Guler; Huseyin Ustun; Murat Kekilli; Mumtaz Dadali; Tugrul Celik; Müzeyyen Astarci; Ibrahim C Haznedaroglu
Journal:  Int J Biomater       Date:  2013-02-20

5.  Clotting Mimicry from Robust Hemostatic Bandages Based on Self-Assembling Peptides.

Authors:  Bryan B Hsu; William Conway; Cory M Tschabrunn; Manav Mehta; Monica B Perez-Cuevas; Shuguang Zhang; Paula T Hammond
Journal:  ACS Nano       Date:  2015-09-02       Impact factor: 15.881

6.  A nanostructured synthetic collagen mimic for hemostasis.

Authors:  Vivek A Kumar; Nichole L Taylor; Abhishek A Jalan; Lyahn K Hwang; Benjamin K Wang; Jeffery D Hartgerink
Journal:  Biomacromolecules       Date:  2014-04-02       Impact factor: 6.988

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.